Top compounds associated with response to AL365202.1


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.012 0.7
mRNA AZD6482 CTRPv2 pan-cancer AAC -0.013 0.7
mRNA procarbazine CTRPv2 pan-cancer AAC -0.013 0.7
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.012 0.7
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.012 0.7
mRNA staurosporine CTRPv2 pan-cancer AAC -0.025 0.7
mRNA MI-1 CTRPv2 pan-cancer AAC 0.013 0.7
mRNA BRD-K78574327 CTRPv2 pan-cancer AAC 0.025 0.7
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.012 0.7
mRNA BRD9647 CTRPv2 pan-cancer AAC 0.012 0.7
Download CSV